BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Makers Laboratories Ltd. Share Price

NSE
BSE

BSE : 506919

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹159.00
Day's Range ₹153.50 - ₹162.60
Open ₹155.15
52 Week Range ₹109.00 - ₹173.70
Volume 33,116
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 52.65
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 75.31
TTM EPS (₹) 2.06
P/E Ratio 10.16
Book Value(₹) 1.25
PAT Margin (%) 9.03
Face Value (₹) 10.00
ROCE(%) 19.01

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 94.51 490.89
Expenses N/A N/A
PBT -8.49 -69.58
Operating profit 0.0 0.0
Net profit -7.71 -69.52

Shareholding Pattern

Promoters (% Holding)

61.27%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.72%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Makers Laboratories Ltd.

Founded 1984

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,49,251.48 1,846.65 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,78,242.24 6,637.50 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,52,951.96 4,380.05 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,16,191.66 8,025.00 6,696.50 - 6,696.50
Dr. Reddy's Laboratories Ltd. 1,06,811.05 1,268.50 1,143.90 - 1,143.90
Cipla Ltd. 1,05,391.40 1,295.15 1,165.70 - 1,165.70
Lupin Ltd. 1,02,674.68 2,240.70 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,01,937.63 2,377.45 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 1,01,003.24 1,017.65 903.00 - 903.00
Zydus Lifesciences Ltd. 96,261.37 932.00 835.50 - 835.50
no-content No Records Found

Latest News

Feb
11
2026
EQUITY Posted on Feb 11th 2026

Makers Laboratories informs about newspaper publication

Pursuant to Regulation 30 under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Makers Laboratories has enclosed copies of the Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2025 published on 11th February, 2026 in Business Standard (all India editions) and Nav Shakti (in Marathi).
The above information is a part of company’s filings submitted to BSE. 
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Bal Pharma informs about resignation of CS cum CO

Bal Pharma has informed that Abdul Basith ( M.NO.A70640), Company Secretary & Compliance Officer of the Company has tendered his resignation vide his letter dated 2nd March, 2026 and the same has been accepted on 11.05.2026. Abdul Basith will be relieved from the services of the Company with effective from close of business hours on Monday, 11th May, 2026. The required details pursuant to the SEBI Listing Regulations are annexed as Annexure-I. Further communication is made about the appointment of new Company Secretary & Compliance Officer, all the communications in relation to the Company be sent to secretarial@balpharma.com 
The above information is a part of company’s filings submitted to BSE.
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Viyash Scientific informs about board meeting

Viyash Scientific has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 19, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026; recommend dividend, if any, on the equity shares of the Company for the year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Bharat Parenterals informs about earnings call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that the Earnings Conference Call to discuss operational and financial performance of the Company for the quarter and Year ended on March 31, 2026 is scheduled to be held on Tuesday, May 19, 2026 at 03:00 pm (I.S.T.). The Invitation for the Q4FY26 Earnings Conference Call is annexed.

The above information is a part of company’s filings submitted to BSE.

Read More
May
12
2026
COMPANY Posted on May 12th 2026

Asarfi Hospital Ltd. - Quaterly Results

The sales figure stood at Rs. 450.35 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 28.29% as compared to Rs. 351.04 millions during the year-ago period.Net profit stood at Rs. 40.91  millions  compared to Rs. 38.28 millions in the corresponding previous quarter,high by 6.87%.Operating profit for the quarter ended March 2026 decreased to 85.21 millions as compared to 101.13 millions of corresponding quarter ended March 2025.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 450.35 351.04 28.29 1731.97 1217.78 42.22 1731.97 1217.78 42.22
Other Income 6.65 36.57 -81.82 27.85 63.57 -56.19 27.85 63.57 -56.19
PBIDT 85.21 101.13 -15.74 382.95 314.14 21.90 382.95 314.14 21.90
Interest 7.05 13.48 -47.70 42.44 40.81 3.99 42.44 40.81 3.99
PBDT 78.16 87.65 -10.83 340.51 273.33 24.58 340.51 273.33 24.58
Depreciation 27.43 32.30 -15.08 114.42 126.17 -9.31 114.42 126.17 -9.31
PBT 50.73 55.35 -8.35 226.09 147.16 53.64 226.09 147.16 53.64
TAX 9.82 17.07 -42.47 55.33 37.36 48.10 55.33 37.36 48.10
Deferred Tax -5.84 2.66 -319.55 -3.47 6.55 -152.98 -3.47 6.55 -152.98
PAT 40.91 38.28 6.87 170.76 109.80 55.52 170.76 109.80 55.52
Equity 196.77 196.77 0.00 196.77 196.77 0.00 196.77 196.77 0.00
PBIDTM(%) 18.92 28.81 -34.32 22.11 25.80 -14.29 22.11 25.80 -14.29
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Makers Laboratories Ltd. ?

The current share price of Makers Laboratories Ltd. is ₹159.00 as of 2026-05-12.

The market capitalisation of Makers Laboratories Ltd. is ₹91.43 as of 2026-05-11.

The 1-year return of Makers Laboratories Ltd. is 28.70% as of 2025-05-09.

The P/E ratio of Makers Laboratories Ltd. is 10.16 as of 2026-05-12.

The 52-week high and low of Makers Laboratories Ltd. are ₹173.70 and ₹109.00, respectively, as of 2026-05-12.

The dividend yield of Makers Laboratories Ltd. is 0.0% as of2026-05-11.

You can buy Makers Laboratories Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Makers Laboratories Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore